search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


e-Monitoring of Asthma Therapy to Improve Compliance in children.


- candidate number8613
- NTR NumberNTR2583
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR2-nov-2010
- Secondary IDs34219 ABR
- Public Titlee-Monitoring of Asthma Therapy to Improve Compliance in children.
- Scientific TitleThe use of a Real-Time Medication Monitoring system (RTMM) for the improvement of adherence to inhalation corticosteroids in children with asthma.
- ACRONYMe-MATIC
- hypothesisAdherence to inhaled corticosteroids in children with asthma will improve by sending tailored sms-reminders to the parents.
- Healt Condition(s) or Problem(s) studiedAsthma, Inhaled corticosteroids, Compliance, Real time medication monitoring (RTMM), Text-messaging reminder
- Inclusion criteria1. Children younger than 12 years old;
2. Diagnosed with asthma for at least 6 months;
3. ICS use for at least 3 months using a pMDI;
4. At least one parent or care giver has a mobile phone.
- Exclusion criteriaRefusal to participate in the study.
- mec approval receivedno
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jan-2011
- planned closingdate31-dec-2012
- Target number of participants220
- InterventionsAll children will receive a real time medication monitoring (RTMM) device that is connected to the pressurized metered dose inhaler (pMDI) with inhaled corticosteroids (ICS). Immediately after each inhalation, a signal is sent to the research database. This information is compared to the expected time of inhalation and thus adherence is determined. Only in the intervention group, sms-reminders are sent to parents of children that are at risk of forgetting to take their ICS.
- Primary outcomePercentage of inhalations taken within a 6 hour timeframe around the expected time of inhalation.
- Secondary outcome1. Asthma controll;
2. Asthma exacerbations;
3. Disease specific quality of life;
4. Acceptance of e-monitoring bij parents and children.
Moreover, an economic evaluation will be performed adopting a societal perspective, including all relevant healthcare costs and productivity loss of the parents.
- TimepointsThe study period per patient is one year.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESDrs. E.C. Vasbinder
- CONTACT for SCIENTIFIC QUERIESDr. P.M.L.A. Bemt, van den
- Sponsor/Initiator Erasmus Medical Center, Evalan BV, GlaxoSmithKline (GSK)
- Funding
(Source(s) of Monetary or Material Support)
ZON-MW, The Netherlands Organization for Health Research and Development
- PublicationsN/A
- Brief summaryBackground:
Asthma still is the most common chronic childhood disease in industrialised countries. Asthma control in children is poor, partly due to poor medication adherence. Effective interventions are needed to improve medication adherence.

Aim:
The aim of the project is to use a Real-Time Medication Monitoring system (RTMM) to improve adherence to inhalation corticosteroids in children with asthma and to study the impact of improved adherence on effectiveness and cost-effectiveness of treatment.

Design:
A multicenter, randomized controlled trial.

Patients:
Included are children (younger than 12 years) with moderate to severe asthma, who have been using inhaled corticosteroids (ICS) as a pressurized metered dose inhaler (pMDI) for asthma for at least 3 months.

Intervention:
All children receive an RTMM-device, but only in the intervention group SMS-messages are sent to the parents and in case the child has a mobile phone - to the child to warn that a dose is at risk of omission. The sms-reminding is tailored in that warnings are only sent if non-adherence is likely to occur.

Outcome measures:
In both groups RTMM data are used to determine adherence, which is the primary outcome measure of this study. This outcome is defined as the percentage of prescribed dosages taken by the child within a 6 our time-frame around the expected time of inhalation (from 3 ours before until 3 hours after). Secondary outcome measures are asthma control, exacerbations and disease-specific quality of life collected through the PAQLQ questionnaire, interviews and medical health records. Online focus groups and patient questionnaires will be used to collect data on parental and children's acceptance of the system. An economic evaluation will be performed adopting a societal perspective, including all relevant healthcare costs and productivity loss of the parents. Furthermore, a decision-analytic model will be developed that includes different levels or forms of adherence and the outcomes, both clinical and costs, attributed to each level or form of adherence as well as different price levels for RTMM.
- Main changes (audit trail)
- RECORD2-nov-2010 - 26-jan-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl